Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients

P Cejkova, P Novota, M Cerna, K Kolostova, D Novakova, P Kucera, J Novak, M Andel, P Weber, E Zdarsky

. 2008 ; 35 (2) : 133-140.

Language English Country Great Britain

Document type Multicenter Study

E-resources

NLK Medline Complete (EBSCOhost) from 2005-02-01 to 1 year ago
Wiley Online Library (archiv) from 1997-01-01 to 2012-12-31

Both the human leucocyte antigen (HLA) DRB1 and the HLA DQB1 gene loci play a role in the development and progression of autoimmune diabetes mellitus (T1DM). Similarly, the insulin promoter variable number tandem repeats (INS-VNTR) polymorphism is also involved in the pathogenesis of diabetes mellitus (DM). We studied the association between each of these polymorphisms and DM diagnosed in patients older than age 35 years. Furthermore, we analysed possible interactions between HLA DRB1/DQB1 and INS-VNTR polymorphisms. Based on C-peptide and GADA levels we were able to distinguish three types of diabetes: T1DM, latent autoimmune diabetes in adults (LADA) and T2DM. INS-VNTR was genotyped indirectly by typing INS-23HphI A/T polymorphism. The genotype and allele frequencies of INS-23HphI did not differ between each of the diabetic groups and group of healthy subjects. We did, however, observe an association between the INS-23HphI alleles, genotypes and C-peptide secretion in all diabetic patients: A allele frequency was 86.2% in the C-peptide-negative group vs. 65.4% in the C-peptide-positive group (P(corr.) < 0.005); AA genotype was found to be 72.4% in the C-peptide-negative group vs. 42.6% in the C-peptide-positive groups (P(corr.) < 0.01). The HLA genotyping revealed a significantly higher frequency of HLA DRB1*03 allele in both T1DM and LADA groups when compared to healthy subjects: T1DM (25.7%) vs. control group (10.15%), odds ratio (OR) = 3.06, P < 0.05; LADA (27.6%) vs. control (10.15%), OR = 3.37, P < 0.01. The simultaneous presence of both HLA DRB1*04 and INS-23HphI AA genotype was detected in 37.5% of the T1DM group compared to only 9.2% of the healthy individuals group (OR = 5.9, P(corr.) < 0.007). We summarize that in the Central Bohemian population of the Czech Republic, the INS-23HphI A allele appears to be associated with a decrease in pancreatic beta cell secretory activity. HLA genotyping points to at least a partial difference in mechanism, which leads to T1DM and LADA development as well as a more diverse genetic predisposition in juvenile- and adult-onset diabetes. The simultaneous effect of HLA and INS-VNTR alleles/genotypes predispose individuals to an increased risk of diabetes development.

000      
04558naa 2200613 a 4500
001      
bmc11003051
003      
CZ-PrNML
005      
20121123105603.0
008      
110225s2008 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Daňková, Pavlína $7 xx0146621
245    10
$a HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients / $c P Cejkova, P Novota, M Cerna, K Kolostova, D Novakova, P Kucera, J Novak, M Andel, P Weber, E Zdarsky
314    __
$a Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Pavlina.Cejkova@lf3.cuni.cz
520    9_
$a Both the human leucocyte antigen (HLA) DRB1 and the HLA DQB1 gene loci play a role in the development and progression of autoimmune diabetes mellitus (T1DM). Similarly, the insulin promoter variable number tandem repeats (INS-VNTR) polymorphism is also involved in the pathogenesis of diabetes mellitus (DM). We studied the association between each of these polymorphisms and DM diagnosed in patients older than age 35 years. Furthermore, we analysed possible interactions between HLA DRB1/DQB1 and INS-VNTR polymorphisms. Based on C-peptide and GADA levels we were able to distinguish three types of diabetes: T1DM, latent autoimmune diabetes in adults (LADA) and T2DM. INS-VNTR was genotyped indirectly by typing INS-23HphI A/T polymorphism. The genotype and allele frequencies of INS-23HphI did not differ between each of the diabetic groups and group of healthy subjects. We did, however, observe an association between the INS-23HphI alleles, genotypes and C-peptide secretion in all diabetic patients: A allele frequency was 86.2% in the C-peptide-negative group vs. 65.4% in the C-peptide-positive group (P(corr.) < 0.005); AA genotype was found to be 72.4% in the C-peptide-negative group vs. 42.6% in the C-peptide-positive groups (P(corr.) < 0.01). The HLA genotyping revealed a significantly higher frequency of HLA DRB1*03 allele in both T1DM and LADA groups when compared to healthy subjects: T1DM (25.7%) vs. control group (10.15%), odds ratio (OR) = 3.06, P < 0.05; LADA (27.6%) vs. control (10.15%), OR = 3.37, P < 0.01. The simultaneous presence of both HLA DRB1*04 and INS-23HphI AA genotype was detected in 37.5% of the T1DM group compared to only 9.2% of the healthy individuals group (OR = 5.9, P(corr.) < 0.007). We summarize that in the Central Bohemian population of the Czech Republic, the INS-23HphI A allele appears to be associated with a decrease in pancreatic beta cell secretory activity. HLA genotyping points to at least a partial difference in mechanism, which leads to T1DM and LADA development as well as a more diverse genetic predisposition in juvenile- and adult-onset diabetes. The simultaneous effect of HLA and INS-VNTR alleles/genotypes predispose individuals to an increased risk of diabetes development.
650    _2
$a dospělí $7 D000328
650    _2
$a věk při počátku nemoci $7 D017668
650    _2
$a alely $7 D000483
650    _2
$a diabetes mellitus 1. typu $x genetika $x imunologie $7 D003922
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a frekvence genu $x genetika $x imunologie $7 D005787
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a HLA-DQ antigeny $x genetika $x imunologie $7 D006683
650    _2
$a HLA-DR antigeny $x genetika $x imunologie $7 D006684
650    _2
$a lidé $7 D006801
650    _2
$a inzulin $x genetika $x imunologie $7 D007328
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a minisatelitní repetice $x genetika $7 D018598
650    _2
$a Minisatellite Repeats $x im [Immunology]
650    _2
$a Polymorphism, Genetic
650    _2
$a Promoter Regions, Genetic $x ge [Genetics]
650    _2
$a Promoter Regions, Genetic $x im [Immunology]
650    _2
$a Risk Factors
651    _2
$a Česká republika $7 D018153
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Novota, Peter $7 xx0061182
700    1_
$a Černá, Marie, $d 1964- $7 mzk2004258459
700    1_
$a Kološtová, Katarína. $7 xx0207726
700    1_
$a Nováková, Dana, $d 1950- $7 xx0079110
700    1_
$a Kučera, Petr, $d 1957- $7 xx0070805
700    1_
$a Novák, Jan, $d 1974- $7 xx0074930
700    1_
$a Anděl, Michal, $d 1946- $7 jn19981228006
700    1_
$a Weber, Pavel $7 xx0102175
700    1_
$a Žďárský, Emanuel, $d 1957- $7 jn20000402981
773    0_
$t International Journal of Immunogenetics $w MED00008484 $g Roč. 35, č. 2 (2008), s. 133-140
910    __
$a ABA008 $b x $y 1
990    __
$a 20110413114125 $b ABA008
991    __
$a 20121123105626 $b ABA008
999    __
$a ok $b bmc $g 830445 $s 695043
BAS    __
$a 3
BMC    __
$a 2008 $b 35 $c 2 $d 133-140 $m International journal of immunogenetics $n Int J Immunogen $x MED00008484
LZP    __
$a 2011-2B/dkme

Find record